![Nima Farzan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nima Farzan
Vorstandsvorsitzender bei
LATIGO BIOTHERAPEUTICS, INC.
Vermögen: 2 Mio $ am 30.09.2026
Profil
Nima M.
Farzan is President, Chief Executive Officer & Director at Latigo Biotherapeutics, Inc. since 2024.
Mr. Farzan is an Independent Director at Keros Therapeutics, Inc. since 2020.
Mr. Farzan is a Director at the Coalition for Epidemic Preparedness Innovations.
Mr. Farzan is a Trustee at The Hamlin School.
Former roles include President, Chief Executive Officer & Director at Kinnate Biopharma, Inc. from 2020 to 2024.
President, Chief Executive Officer & Director at Emergent Travel Health, Inc. from 2015 to 2018.
President & Chief Executive Officer at Paxvax Corp.
from 2015 to 2018.
Director-Strategic Marketing at DoubleTwist, Inc. from 1997 to 1999.
Director-Disease Area Strategy at Novartis AG from 2003 to 2011.
Vice President-Marketing at Novartis Vaccines & Diagnostics, Inc. Venture Partner at Foresite Capital Management LLC in 2024.
Associate at The Boston Consulting Group, Inc. from 1997 to 1999.
Education includes undergraduate degree from Stanford University and MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.08.2026 | 114’453 ( 0.17% ) | 2 Mio $ | 30.09.2026 | |
| 04.06.2026 | 9’767 ( 0.05% ) | 111 344 $ | 30.09.2026 |
Aktive Positionen von Nima Farzan
| Unternehmen | Position | Beginn |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2020 |
| LATIGO BIOTHERAPEUTICS, INC. | Vorstandsvorsitzender | 22.07.2024 |
The Hamlin School
 The Hamlin School Other Consumer ServicesConsumer Services Operates as a school for girls | Corporate Officer/Principal | - |
Coalition for Epidemic Preparedness Innovations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Nima Farzan
| Unternehmen | Position | Ende |
|---|---|---|
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Corporate Officer/Principal | 01.07.2024 |
| KINNATE BIOPHARMA INC. | Vorstandsvorsitzender | 03.04.2024 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Vorstandsvorsitzender | 01.10.2018 |
Paxvax Corp. | Vorstandsvorsitzender | 01.10.2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Nima Farzan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
DoubleTwist, Inc.
 DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genomic information and bioinformatics analysis | Commercial Services |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
The Hamlin School
The Hamlin School Other Consumer ServicesConsumer Services Operates as a school for girls | Consumer Services |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Coalition for Epidemic Preparedness Innovations | |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Latigo Biotherapeutics, Inc.
 Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
Paxvax Corp. |
